Clinical Research Directory
Browse clinical research sites, groups, and studies.
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
Sponsor: BioSensics
Summary
Progressive supranuclear palsy (PSP), mild cognitive impairment with Lewy bodies (MCI-LB), and Dementia with Lewy Bodies (DLB) are severe neurodegenerative diseases that cause significant motor impairment impacting daily function. Researchers at BioSensics, Johns Hopkins School of Medicine, Massachusetts General Hospital and their collaborators aim to conduct an analytical and clinical validation of wearable-based digital health technologies for monitoring upper and lower limb function in PSP, MCI-LB and DLB that could enable frequent, at-home monitoring and be incorporated into future clinical trials.
Official title: Digital Health Technologies For Monitoring Disease Symptoms in Progressive Supranuclear Palsy and Dementia With Lewy Bodies
Key Details
Gender
All
Age Range
40 Years - 89 Years
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2026-06-15
Completion Date
2029-01-01
Last Updated
2026-04-09
Healthy Volunteers
No
Conditions
Locations (2)
Johns Hopkins University School of Medicine
Lutherville, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States